| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Revenue | $864.1M | -18.4% |
| Cost of Revenue | $489.6M | -19.8% |
| Gross Profit | $374.6M | -16.6% |
| R&D Expense | $7.3M | -2.9% |
| SG&A Expense | $72.5M | -8.5% |
| Operating Income | $251.7M | -21.3% |
| Pre-tax Income | $252.4M | -20.6% |
| Income Tax | $57.9M | -22.2% |
| Net Income | $194.5M |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $120.7M | +6.8% |
| Accounts Receivable | $62.7M | -7.0% |
| Current Assets | $327.6M | +22.1% |
| Total Assets | $497.5M | +11.4% |
| Current Liabilities | $88.9M | -29.2% |
| Total Liabilities | $137.0M | -23.9% |
| Stockholders' Equity | $360.5M | +35.3% |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $137.8M | -56.3% |
| Capital Expenditures | $24.0M | +8.7% |
| Investing Cash Flow | -$24.1M | -3.0% |
| Financing Cash Flow | -$106.0M | +65.1% |
| Free Cash Flow | $113.8M | -61.2% |
| -22.8% |
| EPS (Basic) | $4.12 | -10.8% |
| EPS (Diluted) | $4.08 | -10.3% |